13 days ago
JBIO
AnalystsVamil DivanVamil Divan's Stock Forecasts
AnalystsVamil Divan
Analyst Ranking
Top 3%
#159 out of 5279 analysts
Average Return
+19.92%
Win Rate
60%115 out of 191
Risk vs Reward
Poor
Good
Vamil Divan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cabaletta Bio IncCABA | +702.34% | $1.28 | $10.27 | 2022-05-25 - 2023-05-24 | Strong Buy |
Cabaletta Bio IncCABA | +313.27% | $1.96 | $8.10 | 2022-03-18 - 2023-03-17 | Strong Buy |
Insmed IncINSM | +265.91% | $20.36 | $74.50 | 2023-07-26 - 2024-07-25 | Strong Buy |
Jade Biosciences IncJBIO | +235.62% | $6.99 | $23.46 | 2025-06-16 - 2026-05-21 | Strong Buy |
Insmed IncINSM | +185.36% | $26.37 | $75.25 | 2023-09-05 - 2024-09-04 | Strong Buy |
Vamil Divan Analyst Color
Get additional color on Vamil Divan's coverage of popular stocks
a month ago
TVTX
a month ago
TVTX
a month ago
ABBV
2 months ago
ASMB
2 months ago
JBIO
6 months ago
JBIO
7 months ago
ABBV
9 months ago
INSM
9 months ago
ASMB
10 months ago
ABBV
10 months ago
JNJ
10 months ago
PROK
a year ago
ABBV
a year ago
ANIP
a year ago
VERA
a year ago
MRK
a year ago
ABBV
2 years ago
JNJ
2 years ago
ABBV
2 years ago
VERA
2 years ago
TVTX
2 years ago
INSM
2 years ago
VERA
2 years ago
ABBV
Vamil Divan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Unicycive Therapeutics IncUNCY | 3 | Strong Buy | $37.00 | +357.92% | Maintains | 11 days ago |
Draftkings IncDKNG | 1 | Strong Buy | $35.00 | +39.33% | Maintains | 13 days ago |
Jade Biosciences IncJBIO | 5 | Strong Buy | $32.00 | +44.08% | Maintains | 13 days ago |
Insmed IncINSM | 9 | Strong Buy | $226.00 | +112.73% | Maintains | 16 days ago |
Amgen IncAMGN | 4 | Hold | $340.00 | +0.21% | Maintains | 20 days ago |
Abbvie IncABBV | 25 | Strong Buy | $249.00 | +15.44% | Reiterates | 23 days ago |
Travere Therapeutics IncTVTX | 9 | Strong Buy | $56.00 | +26.04% | Maintains | a month ago |
Assembly Biosciences IncASMB | 3 | Strong Buy | $43.00 | +51.73% | Maintains | 2 months ago |
Pfizer IncPFE | 16 | Strong Buy | $36.00 | +39.00% | Maintains | 2 months ago |
Merck & Co IncMRK | 8 | Strong Buy | $140.00 | +14.37% | Maintains | 4 months ago |
Johnson & JohnsonJNJ | 12 | Strong Buy | $240.00 | +2.42% | Maintains | 4 months ago |
Ani Pharmaceuticals IncANIP | 14 | Strong Buy | $124.00 | +49.90% | Maintains | 4 months ago |
Eledon Pharmaceuticals IncELDN | 1 | Strong Buy | $8.00 | +105.66% | Maintains | 6 months ago |
Scynexis IncSCYX | 3 | Strong Buy | $3.00 | +310.40% | Maintains | 7 months ago |
Savara IncSVRA | 2 | Strong Buy | $11.00 | +119.12% | Maintains | 8 months ago |
Valneva SeVALN | 2 | Strong Buy | $13.00 | +119.22% | Maintains | 9 months ago |
Prokidney CorpPROK | 2 | Strong Buy | $7.00 | +300.00% | Maintains | 10 months ago |
Absci CorpABSI | 3 | Strong Buy | $10.00 | N/A | Reiterates | a year ago |
Vera Therapeutics IncVERA | 5 | Strong Buy | $61.00 | N/A | Maintains | a year ago |
Revance Therapeutics IncRVNC | 6 | Hold | $3.10 | N/A | Maintains | a year ago |
Keros Therapeutics IncKROS | 2 | Strong Buy | $102.00 | N/A | Maintains | a year ago |
Alpine Immune Sciences IncALPN | 1 | Strong Buy | $55.00 | N/A | Initiates Coverage On | 2 years ago |
Karuna Therapeutics IncKRTX | 7 | Hold | $330.00 | N/A | Downgrades | 2 years ago |
Sage Therapeutics IncSAGE | 7 | Hold | $20.00 | N/A | Maintains | 3 years ago |
Calliditas Therapeutics AbCALT | 2 | Hold | $18.00 | N/A | Maintains | 3 years ago |
Relmada Therapeutics IncRLMD | 2 | Strong Buy | $26.00 | N/A | Reiterates | 3 years ago |
Chinook Therapeutics IncKDNY | 3 | Hold | $40.00 | N/A | Downgrades | 3 years ago |
Satsuma Pharmaceuticals IncSTSA | 5 | Hold | $2.00 | N/A | Downgrades | 4 years ago |
Acadia Pharmaceuticals IncACAD | 7 | Hold | $19.00 | N/A | Maintains | 4 years ago |
Neurocrine Biosciences IncNBIX | 5 | Hold | $98.00 | N/A | Maintains | 4 years ago |
Alkermes PLCALKS | 7 | Strong Buy | $34.00 | N/A | Maintains | 4 years ago |
Cabaletta Bio IncCABA | 3 | Strong Buy | $10.00 | N/A | Maintains | 4 years ago |
Axsome Therapeutics IncAXSM | 3 | Strong Buy | $49.00 | N/A | Maintains | 4 years ago |
Eli Lilly & CoLLY | 12 | Strong Buy | $356.00 | N/A | Maintains | 4 years ago |
Xeris Biopharma Holdings IncXERS | 1 | Strong Buy | $6.00 | N/A | Maintains | 4 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 9 | Strong Buy | $154.00 | N/A | Maintains | 4 years ago |
Evolus IncEOLS | 4 | Strong Buy | $15.00 | N/A | Upgrades | 5 years ago |
Allergan PLCAGN | 9 | Hold | $155.00 | N/A | Maintains | 7 years ago |
Teva Pharmaceutical Industries LtdTEVA | 10 | Hold | $20.00 | N/A | Maintains | 7 years ago |
Lakefront Biotherapeutics NvLKFT | 3 | Buy | N/A | N/A | Upgrades | 7 years ago |
Portola Pharmaceuticals IncPTLA | 6 | Hold | $30.00 | N/A | Maintains | 8 years ago |
Alder Biopharmaceuticals IncALDR | 2 | Hold | $17.00 | N/A | Maintains | 8 years ago |
Corvus Pharmaceuticals IncCRVS | 3 | Buy | $15.00 | N/A | Assumes | 8 years ago |
Aimmune Therapeutics IncAIMT | 3 | Buy | $40.00 | N/A | Maintains | 8 years ago |
Bristol Myers Squibb CoBMY | 2 | Hold | $61.00 | N/A | Maintains | 8 years ago |
Allena Pharmaceuticals IncALNAQ | 2 | Buy | $21.00 | N/A | Maintains | 8 years ago |
Esperion Therapeutics IncESPR | 2 | Buy | $103.00 | N/A | Initiates Coverage On | 8 years ago |
Myokardia IncMYOK | 1 | Buy | $55.00 | N/A | Maintains | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.